Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia

Recruiting N/A Interventional Study
Congenital Diaphragmatic Hernia Pulmonary Hypoplasia Pulmonary; Hypertension
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Children's Hospital Medical Center, Cincinnati · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Isolated CDH with liver up * Severe pulmonary hypoplasia with ultrasound O/E LHR \<25% at the time of surgery * Gestational age at FETO procedure 27 weeks 0 days to 29 weeks 6 days * Moderate pulmonary hypoplasia with ultrasound O/E LHR \<30% and liver-up at the time of surger…
Contacts

Foong-Yen Lim, MD

(513) 636-6259

Foong-Yen.Lim@cchmc.org

CONTACT

Jose Peiro, MD, PhD

(513) 803-4563

Jose.Peiro@cchmc.org

CONTACT